2018
Surveillance of Maternal Syphilis in China: Pregnancy Outcomes and Determinants of Congenital Syphilis
Zhang X, Yu Y, Yang H, Xu H, Vermund SH, Liu K. Surveillance of Maternal Syphilis in China: Pregnancy Outcomes and Determinants of Congenital Syphilis. Medical Science Monitor 2018, 24: 7727-7735. PMID: 30370903, PMCID: PMC6216479, DOI: 10.12659/msm.910216.Peer-Reviewed Original ResearchConceptsAdverse pregnancy outcomesPregnancy outcomesCongenital syphilisPregnant womenFirst antenatal care visitEligible pregnant womenPrevention of motherAntenatal care visitsIndependent risk factorMultivariable regression analysisLogistic regression analysisRegression analysisChild transmissionMaternal syphilisAntenatal careCare visitsNeonatal asphyxiaNeonatal deathFirst trimesterRisk womenAntibody titersAntenatal testingEpidemiological characteristicsRisk factorsSyphilis diagnosis
2007
Influence of body mass index on pregnancy outcomes among HIV‐infected and HIV‐uninfected Zambian women
Banda Y, Chapman V, Goldenberg RL, H. B, Vermund SH, Stringer JS. Influence of body mass index on pregnancy outcomes among HIV‐infected and HIV‐uninfected Zambian women. Tropical Medicine And International Health 2007, 12: 856-861. PMID: 17596253, PMCID: PMC2570322, DOI: 10.1111/j.1365-3156.2007.01857.x.Peer-Reviewed Original ResearchConceptsBody mass indexPregnancy outcomesBirth weightInfant weightMass indexZambian womenBMI unitsLower body mass indexChild transmission ratePerinatal HIV transmissionPrevention of motherHIV viral loadInfant birth weightMean birth weightTransmission of HIVNevirapine administrationPrior stillbirthBMI quartilesCD4 countChild transmissionViral loadHIV transmissionMaternal parityUnivariate analysisClinical trials
2006
Use of Vaginally Administered Chlorhexidine During Labor to Improve Pregnancy Outcomes
Goldenberg RL, McClure EM, Saleem S, Rouse D, Vermund S. Use of Vaginally Administered Chlorhexidine During Labor to Improve Pregnancy Outcomes. Obstetrics And Gynecology 2006, 107: 1139-1146. PMID: 16648420, DOI: 10.1097/01.aog.0000215000.65665.dd.Peer-Reviewed Original ResearchConceptsPregnancy outcomesHuman immunodeficiency virusExcellent safety profileGroup B streptococciUse of chlorhexidineChild transmissionNeonatal sepsisNeonatal infectionChlorhexidine useVaginal treatmentImmunodeficiency virusNeonatal mortalityPregnant womenSafety profileAdverse outcomesNewborn periodSTUDY SELECTIONB streptococciPromising treatmentChlorhexidine treatmentBacterial loadChlorhexidineEffective killersEnglish literatureFurther studies
1996
Pregnancy and cervical infection with human papillomaviruses
Morrison E, Gammon MD, Goldberg GL, Vermund SH, Burk RD. Pregnancy and cervical infection with human papillomaviruses. International Journal Of Gynecology & Obstetrics 1996, 54: 125-130. PMID: 9236309, DOI: 10.1016/0020-7292(96)02694-x.Peer-Reviewed Original ResearchConceptsPrevalence odds ratiosHPV risk factorsRisk factorsHPV infectionCurrent pregnancyCervical HPV infectionPrevalence of HPVHuman papillomavirus infectionAssociation of pregnancyStatistical significanceLarge municipal hospitalSelf-administered questionnaireRace/ethnicityCervicovaginal lavageCervical infectionPapillomavirus infectionHPV DNAGestational ageGynecological examinationOutpatient clinicHuman papillomavirusSignificant confoundersOdds ratioLavage samplesMunicipal Hospital
1992
Human immunodeficiency virus/acquired immunodeficiency syndrome in pregnant women
Vermund S, Galbraith M, Ebner S, Sheon A, Kaslow R. Human immunodeficiency virus/acquired immunodeficiency syndrome in pregnant women. Annals Of Epidemiology 1992, 2: 773-802. PMID: 1342332, DOI: 10.1016/1047-2797(92)90072-x.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeFemaleHumansInfant, NewbornPregnancyPregnancy Complications, InfectiousPregnancy OutcomeRisk FactorsConceptsPregnant womenClinical outcomesHuman immunodeficiency virus/Anti-Pneumocystis drugsCells/mm3Adverse clinical outcomesHigh-risk womenHuman immunodeficiency virusLarge multicenter studyImmunodeficiency syndrome (AIDS) epidemicAdequate clinical treatmentHealth care servicesClinical decision makingPerinatal transmissionSelective immunosuppressionHIV diseaseImmunosuppressed womenAvailable antiviralsHIV infectionImmunodeficiency syndromeImmunodeficiency virusMulticenter studyVirus/Therapeutic decisionsHigh risk